• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > How immune responses differ between asymptomatic cases and people with severe COVID-19

How immune responses differ between asymptomatic cases and people with severe COVID-19

How immune responses differ between asymptomatic cases and people with severe COVID-19

Published on 26 April, 2021

People infected with SARS-CoV-2 experience a large range in severity of infection. Menna Clatworthy’s group has taken part in the largest study of its type to investigate differences in the immune response that could explain this variation.

First atomic model of human telomerase constructed by electron cryo-microscopy

Published on 21 April, 2021

Telomerase is a vital enzyme which synthesizes telomeric repeats at eukaryotic chromosome ends to compensate for loss generated by incomplete genome replication. Kelly Nguyen’s group has produced the first atomic structure of the complex and revealed histones as novel subunits.

2021 Max Perutz Lecture to be given by David Baker

Published on 20 April, 2021

David Baker will deliver the 2021 Max Perutz Lecture: ‘The coming of age of de novo protein design.’

LMB honoured in Cambridge Independent Science and Technology Awards

Published on 20 April, 2021

The LMB has received a Special Commendation in the category of Covid-19 Response Award, in the Cambridge Independent Science and Technology Awards. Also highly commended was Zunlong Ke, from John Briggs’ group in our Structural Studies Division, in the category of Researcher of the Year. More…

Repeating peptides are obstacles to neuronal transport in motor neurone disease

Published on 19 April, 2021

Repetitive peptides from the C9orf72 gene contribute to the most prevalent form of motor neurone disease, but it has been unclear how. Simon Bullock’s group help show how these peptides bind to both motor proteins and microtubule tracks to block neuronal transport.

Why humans have such big brains

Published on 6 April, 2021

The Guardian covers how Madeline Lancaster’s group in the Cell Biology division has used brain organoids to trace the origin of human’s larger brain size to the ZEB2 gene, which ‘switches on’ in early cerebral development. More…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Interim pages omitted …
  • Page 327
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.